anaheim-marriott

AGENDA

7:00      Registration, Breakfast, Exhibits.

8:00      Angina Pectoris: definition, classification, and treatment overview.

Joe Caceres, MD

8:20    Guest Introduction

8:25      Options for the “No-option”  Refractory Angina Pectoris Patient.

Timothy Henry, MD

9:05 Role of Enhanced External Counterpulsation in Refractory Angina Pectoris.

Rohit Arora, MD

9:30    Questions and Answers

10:15 Break in the Exhibit Hall

10:30 When to refer for EECP: An interventional cardiologist perspective.

Rex Winters, MD

11:00 EECP – hope for hopeless patients.

Pratiksha Gandhi, MD

11:30 My personal experience with EECP.

Patient testimonials

11:50 Questions and Answers

12:15 Lunch –a three course plated lunch will be served

1 pm Adjourn

 

FACULTY

Timothy Henry, MD, FACC, FAHA, FSCAI
Lee and Harold Kapelovitz Chair in Research Cardiology.
Professor of Medicine
Director, Division of Cardiology
Cedars Sinai Medical Center, Los Angeles, CA
David Geffen School of Medicine, UCLA

Rohit R. Arora, MD, FACC, FAHA, FSCAI
Professor of Medicine
Professor of Physiology and Biophysics
Chairman, Division of Cardiovascular Medicine
The Chicago Medical School

Rex J. Winters, MD, FACC, FAHA
Long Beach Memorial Heart and Vascular Institute
Medical Director of Invasive Cardiology

Pratiksha Gandhi, MD
IPC Heartcare Center LLC

Joe A. Cáceres, MD, FAHA, FAAC
Anaheim Regional Medical Center
Cardiovascular Medicine and Interventional Cardiology

 

STATEMENT OF NEED

An increased number of patients develop advanced coronary artery disease (CAD) with ongoing angina pectoris (AP) not amenable to percutaneous or surgical revascularization. Many have refractory AP despite optimal medical therapy. Treatment options for these patients have been limited to traditional anti-angina therapy and secondary CAD risk-factors modification.

Enhanced External Counterpulsation (EECP) is one alternative strategy for the “No-Option” refractory AP patient. EECP remains an underutilized therapy where many cardiologists and practitioners do not have hands-on experience or have not been exposed to this noninvasive technique that simulates the action of an intra-aortic balloon pump (IABP).

 

TARGET AUDIENCE

This educational program is intended for cardiologists, primary care physicians, patient care providers, nurses, and other allied health professionals in the area of cardiovascular disease who:

  • care for patients with coronary artery disease
  • seek to enhance their understanding of the treatment options for ischemic heart disease, and
  • are interested to know the role of EECP in the management of patients with AP.

 

DESIRED EDUCATIONAL OUTCOMES

  • Recognize angina pectoris and its functional classification as a common symptom of ischemic heart disease.
  • Understand the role and efficacy of EECP in the management of selective patients with ischemic heart disease.
  • Distinguish the advantages and dis-advantages of EECP vs. PCI in patients with angina pectoris associated with obstructive CAD.
  • Identify patients who may benefit from EECP as a unique therapy which provides significant acute and long term relief of angina symptoms and improves quality of life of patients with CAD.
  • Consider EECP as a primary therapy for those patients with high risk/low benefit revascularization profiles.

SPONSOR

This symposium will serve as an educational forum for Southern California cardiologists, physicians, and other allied health professionals for the scientific exchange of information regarding EECP in the treatment of refractory angina pectoris.

This educational program is totally supported by Buena Park Heart Center and the participation of industry exhibitors.